Type 2 diabetes mellitus interacts with obesity and common variations in PLTP to affect plasma phospholipid transfer protein activity

Phospholipid Transfer Protein in Human Plasma Associates with Proteins Linked to Immunity and Inflammation

(2010) Marian C. Cheung et al.   BIOCHEMISTRY

Genetic Variation at the Phospholipid Transfer Protein Locus Affects Its Activity and High-Density Lipoprotein Size and Is a Novel Marker of Cardiovascular Disease Susceptibility

(2010) Menno Vergeer et al.   CIRCULATION

LXR-SREBP-1c-Phospholipid Transfer Protein Axis Controls Very Low Density Lipoprotein (VLDL) Particle Size

(2009) Hiroaki Okazaki et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Genetic and nongenetic sources of variation in phospholipid transfer protein activity

(2009) Gail P. Jarvik et al.   JOURNAL OF LIPID RESEARCH

Effects of Weight Loss on Lipid Transfer Proteins in Morbidly Obese Women

(2009) Markus W. Laimer et al.   LIPIDS

Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor

(2009) T. Tzotzas et al.   Obesity Reviews

PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGeneStudy

(2008) Axel Schlitt et al.   JOURNAL OF LIPID RESEARCH

Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia

(2008) Mary B. Engler et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis

(2007) Wilfried Schgoer et al.   ATHEROSCLEROSIS